nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—chronic obstructive pulmonary disease	0.5	1	CpDpCtD
Methylergometrine—HTR2A—chronic obstructive pulmonary disease	0.308	1	CbGaD
Methylergometrine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0228	0.282	CbGbCtD
Methylergometrine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0154	0.19	CbGbCtD
Methylergometrine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0147	0.182	CbGbCtD
Methylergometrine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0131	0.162	CbGbCtD
Methylergometrine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00768	0.0949	CbGbCtD
Methylergometrine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00726	0.0897	CbGbCtD
Methylergometrine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00555	0.569	CbGeAlD
Methylergometrine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00201	0.207	CbGeAlD
Methylergometrine—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.0202	CcSEcCtD
Methylergometrine—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.00111	0.0168	CcSEcCtD
Methylergometrine—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.0168	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.000986	0.015	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.000986	0.015	CcSEcCtD
Methylergometrine—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.000985	0.015	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.000931	0.0142	CcSEcCtD
Methylergometrine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000888	0.0135	CcSEcCtD
Methylergometrine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000855	0.013	CcSEcCtD
Methylergometrine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000855	0.013	CcSEcCtD
Methylergometrine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000817	0.0124	CcSEcCtD
Methylergometrine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000812	0.0124	CcSEcCtD
Methylergometrine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.0123	CcSEcCtD
Methylergometrine—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000752	0.0115	CcSEcCtD
Methylergometrine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00074	0.0113	CcSEcCtD
Methylergometrine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000656	0.00999	CcSEcCtD
Methylergometrine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000656	0.00999	CcSEcCtD
Methylergometrine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00943	CcSEcCtD
Methylergometrine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00943	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000617	0.00939	CcSEcCtD
Methylergometrine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000596	0.00908	CcSEcCtD
Methylergometrine—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000572	0.00872	CcSEcCtD
Methylergometrine—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.00872	CcSEcCtD
Methylergometrine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000545	0.00829	CcSEcCtD
Methylergometrine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00823	CcSEcCtD
Methylergometrine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000534	0.00813	CcSEcCtD
Methylergometrine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000525	0.008	CcSEcCtD
Methylergometrine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000516	0.00786	CcSEcCtD
Methylergometrine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000514	0.00782	CcSEcCtD
Methylergometrine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000511	0.0524	CbGeAlD
Methylergometrine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00766	CcSEcCtD
Methylergometrine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.00764	CcSEcCtD
Methylergometrine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.0005	0.00762	CcSEcCtD
Methylergometrine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.00762	CcSEcCtD
Methylergometrine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000499	0.0076	CcSEcCtD
Methylergometrine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.00754	CcSEcCtD
Methylergometrine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00751	CcSEcCtD
Methylergometrine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000491	0.00748	CcSEcCtD
Methylergometrine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00049	0.00746	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000487	0.00742	CcSEcCtD
Methylergometrine—Methysergide—HTR2A—chronic obstructive pulmonary disease	0.000482	0.165	CrCbGaD
Methylergometrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000479	0.0073	CcSEcCtD
Methylergometrine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000475	0.00724	CcSEcCtD
Methylergometrine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000475	0.00724	CcSEcCtD
Methylergometrine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00722	CcSEcCtD
Methylergometrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000472	0.0072	CcSEcCtD
Methylergometrine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00719	CcSEcCtD
Methylergometrine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00047	0.00716	CcSEcCtD
Methylergometrine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.00708	CcSEcCtD
Methylergometrine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000463	0.00705	CcSEcCtD
Methylergometrine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00687	CcSEcCtD
Methylergometrine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00687	CcSEcCtD
Methylergometrine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000448	0.00682	CcSEcCtD
Methylergometrine—Pergolide—HTR2A—chronic obstructive pulmonary disease	0.000447	0.153	CrCbGaD
Methylergometrine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000442	0.00673	CcSEcCtD
Methylergometrine—Ergotamine—CYP1A2—chronic obstructive pulmonary disease	0.000441	0.151	CrCbGaD
Methylergometrine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00649	CcSEcCtD
Methylergometrine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00648	CcSEcCtD
Methylergometrine—Bromocriptine—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.146	CrCbGaD
Methylergometrine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00631	CcSEcCtD
Methylergometrine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00631	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000411	0.00626	CcSEcCtD
Methylergometrine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000406	0.00618	CcSEcCtD
Methylergometrine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00617	CcSEcCtD
Methylergometrine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00617	CcSEcCtD
Methylergometrine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00608	CcSEcCtD
Methylergometrine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00608	CcSEcCtD
Methylergometrine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00606	CcSEcCtD
Methylergometrine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000398	0.00606	CcSEcCtD
Methylergometrine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00596	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00591	CcSEcCtD
Methylergometrine—Lisuride—HTR2A—chronic obstructive pulmonary disease	0.000388	0.133	CrCbGaD
Methylergometrine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00583	CcSEcCtD
Methylergometrine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00583	CcSEcCtD
Methylergometrine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00582	CcSEcCtD
Methylergometrine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00574	CcSEcCtD
Methylergometrine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00572	CcSEcCtD
Methylergometrine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00572	CcSEcCtD
Methylergometrine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000375	0.00571	CcSEcCtD
Methylergometrine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00571	CcSEcCtD
Methylergometrine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00569	CcSEcCtD
Methylergometrine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00569	CcSEcCtD
Methylergometrine—Ergotamine—HTR2A—chronic obstructive pulmonary disease	0.000373	0.128	CrCbGaD
Methylergometrine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000368	0.0056	CcSEcCtD
Methylergometrine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.0055	CcSEcCtD
Methylergometrine—Bromocriptine—HTR2A—chronic obstructive pulmonary disease	0.000359	0.123	CrCbGaD
Methylergometrine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00545	CcSEcCtD
Methylergometrine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00545	CcSEcCtD
Methylergometrine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.00541	CcSEcCtD
Methylergometrine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.0054	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000354	0.00539	CcSEcCtD
Methylergometrine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00537	CcSEcCtD
Methylergometrine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00532	CcSEcCtD
Methylergometrine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000344	0.00524	CcSEcCtD
Methylergometrine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.0052	CcSEcCtD
Methylergometrine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000341	0.0052	CcSEcCtD
Methylergometrine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000339	0.0347	CbGeAlD
Methylergometrine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00514	CcSEcCtD
Methylergometrine—HTR2B—lung—chronic obstructive pulmonary disease	0.000337	0.0345	CbGeAlD
Methylergometrine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00513	CcSEcCtD
Methylergometrine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00507	CcSEcCtD
Methylergometrine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00494	CcSEcCtD
Methylergometrine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00491	CcSEcCtD
Methylergometrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.00487	CcSEcCtD
Methylergometrine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000317	0.00483	CcSEcCtD
Methylergometrine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000317	0.00483	CcSEcCtD
Methylergometrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.0048	CcSEcCtD
Methylergometrine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00478	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00477	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00477	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00467	CcSEcCtD
Methylergometrine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00461	CcSEcCtD
Methylergometrine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00461	CcSEcCtD
Methylergometrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.00459	CcSEcCtD
Methylergometrine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000299	0.00455	CcSEcCtD
Methylergometrine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000299	0.00455	CcSEcCtD
Methylergometrine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00455	CcSEcCtD
Methylergometrine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000298	0.0306	CbGeAlD
Methylergometrine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00453	CcSEcCtD
Methylergometrine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.00452	CcSEcCtD
Methylergometrine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000296	0.00451	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.0045	CcSEcCtD
Methylergometrine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00435	CcSEcCtD
Methylergometrine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.00429	CcSEcCtD
Methylergometrine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000273	0.028	CbGeAlD
Methylergometrine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00399	CcSEcCtD
Methylergometrine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00399	CcSEcCtD
Methylergometrine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00393	CcSEcCtD
Methylergometrine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00391	CcSEcCtD
Methylergometrine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00385	CcSEcCtD
Methylergometrine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00385	CcSEcCtD
Methylergometrine—HTR2A—trachea—chronic obstructive pulmonary disease	0.00025	0.0257	CbGeAlD
Methylergometrine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00378	CcSEcCtD
Methylergometrine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00377	CcSEcCtD
Methylergometrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00371	CcSEcCtD
Methylergometrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00371	CcSEcCtD
Methylergometrine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00368	CcSEcCtD
Methylergometrine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00368	CcSEcCtD
Methylergometrine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00367	CcSEcCtD
Methylergometrine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00367	CcSEcCtD
Methylergometrine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00365	CcSEcCtD
Methylergometrine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00365	CcSEcCtD
Methylergometrine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00364	CcSEcCtD
Methylergometrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000238	0.00363	CcSEcCtD
Methylergometrine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000236	0.0036	CcSEcCtD
Methylergometrine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000236	0.0036	CcSEcCtD
Methylergometrine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00358	CcSEcCtD
Methylergometrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.0035	CcSEcCtD
Methylergometrine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00347	CcSEcCtD
Methylergometrine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00347	CcSEcCtD
Methylergometrine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00346	CcSEcCtD
Methylergometrine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00346	CcSEcCtD
Methylergometrine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00345	CcSEcCtD
Methylergometrine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00339	CcSEcCtD
Methylergometrine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00335	CcSEcCtD
Methylergometrine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.00334	CcSEcCtD
Methylergometrine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00329	CcSEcCtD
Methylergometrine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00327	CcSEcCtD
Methylergometrine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00321	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00316	CcSEcCtD
Methylergometrine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00308	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00305	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00283	CcSEcCtD
Methylergometrine—HTR2A—lung—chronic obstructive pulmonary disease	0.00018	0.0184	CbGeAlD
Methylergometrine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00244	CcSEcCtD
Methylergometrine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00243	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00229	CcSEcCtD
Methylergometrine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00225	CcSEcCtD
Methylergometrine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00224	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00222	CcSEcCtD
Methylergometrine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00209	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00206	CcSEcCtD
Methylergometrine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00199	CcSEcCtD
Methylergometrine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00199	CcSEcCtD
Methylergometrine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00198	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00188	CcSEcCtD
Methylergometrine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00188	CcSEcCtD
Methylergometrine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00181	CcSEcCtD
Methylergometrine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00157	CcSEcCtD
Methylergometrine—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.00152	CcSEcCtD
Methylergometrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.00146	CcSEcCtD
Methylergometrine—Rash—Prednisone—chronic obstructive pulmonary disease	9.5e-05	0.00145	CcSEcCtD
Methylergometrine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.00145	CcSEcCtD
Methylergometrine—Headache—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.00144	CcSEcCtD
Methylergometrine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.00136	CcSEcCtD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.02e-05	0.0015	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.01e-05	0.0015	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	4.96e-05	0.00149	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.93e-05	0.00148	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.78e-05	0.00143	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.77e-05	0.00143	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.74e-05	0.00142	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.74e-05	0.00142	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.72e-05	0.00142	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.67e-05	0.0014	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.65e-05	0.0014	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.54e-05	0.00136	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.51e-05	0.00135	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.48e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.47e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.45e-05	0.00133	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.44e-05	0.00133	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.41e-05	0.00132	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.3e-05	0.00129	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.23e-05	0.00127	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.19e-05	0.00126	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.16e-05	0.00125	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.09e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.06e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.06e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.05e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.05e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.04e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.04e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.99e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.98e-05	0.00119	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.94e-05	0.00118	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.9e-05	0.00117	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.89e-05	0.00117	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.86e-05	0.00116	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.86e-05	0.00116	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.85e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.83e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.82e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.82e-05	0.00115	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.81e-05	0.00114	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.7e-05	0.00111	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.68e-05	0.0011	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.67e-05	0.0011	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.64e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.63e-05	0.00109	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.58e-05	0.00108	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.56e-05	0.00107	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.51e-05	0.00105	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.49e-05	0.00105	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.46e-05	0.00104	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.36e-05	0.00101	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.27e-05	0.000981	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.26e-05	0.000976	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.000968	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.17e-05	0.000952	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.15e-05	0.000944	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.13e-05	0.000938	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.11e-05	0.000934	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.11e-05	0.000933	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.11e-05	0.000932	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.09e-05	0.000926	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.09e-05	0.000926	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.96e-05	0.000889	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.96e-05	0.000887	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.95e-05	0.000885	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.83e-05	0.000848	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.8e-05	0.000838	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.79e-05	0.000836	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.79e-05	0.000836	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.75e-05	0.000826	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.73e-05	0.00082	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.73e-05	0.000819	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.69e-05	0.000807	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.66e-05	0.000799	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.63e-05	0.000788	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.6e-05	0.000779	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.58e-05	0.000774	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.54e-05	0.000762	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.53e-05	0.000759	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.52e-05	0.000757	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.000752	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.49e-05	0.000747	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.49e-05	0.000747	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000742	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.4e-05	0.000719	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.39e-05	0.000716	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.39e-05	0.000716	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.38e-05	0.000715	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.38e-05	0.000714	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000713	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.37e-05	0.000712	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.36e-05	0.000708	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.35e-05	0.000705	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.000703	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.000686	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.27e-05	0.000681	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.26e-05	0.000678	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.25e-05	0.000674	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.25e-05	0.000674	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.25e-05	0.000674	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.19e-05	0.000657	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.18e-05	0.000654	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.16e-05	0.000649	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.16e-05	0.000648	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.15e-05	0.000645	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.14e-05	0.000643	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.13e-05	0.00064	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.08e-05	0.000623	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.07e-05	0.000621	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.06e-05	0.000619	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.06e-05	0.000616	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.04e-05	0.000612	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.01e-05	0.000603	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.99e-05	0.000596	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.98e-05	0.000593	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.96e-05	0.000588	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.95e-05	0.000586	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.95e-05	0.000584	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.92e-05	0.000577	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.92e-05	0.000576	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.91e-05	0.000574	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.91e-05	0.000574	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.87e-05	0.000562	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.87e-05	0.00056	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.85e-05	0.000554	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.82e-05	0.000547	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000532	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.76e-05	0.000527	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.000523	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.74e-05	0.000523	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.74e-05	0.000523	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.67e-05	0.000501	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.67e-05	0.000501	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000499	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.64e-05	0.000493	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.62e-05	0.000486	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.6e-05	0.000479	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000475	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.53e-05	0.000458	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.52e-05	0.000456	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.5e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.45e-05	0.000435	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.43e-05	0.00043	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.41e-05	0.000423	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.41e-05	0.000422	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.000415	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.37e-05	0.00041	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.35e-05	0.000404	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.000401	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.31e-05	0.000392	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000392	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000381	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.00038	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.26e-05	0.000378	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.00037	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.23e-05	0.000368	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000367	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.22e-05	0.000366	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.21e-05	0.000364	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.21e-05	0.000362	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000351	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.17e-05	0.00035	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000347	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.15e-05	0.000346	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.000344	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.15e-05	0.000344	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.14e-05	0.00034	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.11e-05	0.000333	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.1e-05	0.000331	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.1e-05	0.00033	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.09e-05	0.000326	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000326	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.08e-05	0.000323	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.05e-05	0.000314	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000314	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.02e-05	0.000307	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.97e-06	0.000299	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.86e-06	0.000296	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.8e-06	0.000294	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.43e-06	0.000283	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.43e-06	0.000283	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.41e-06	0.000282	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.36e-06	0.000281	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.15e-06	0.000274	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.97e-06	0.000269	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.94e-06	0.000268	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.77e-06	0.000263	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.63e-06	0.000259	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.57e-06	0.000257	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.53e-06	0.000256	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.51e-06	0.000255	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.47e-06	0.000254	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.43e-06	0.000253	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.14e-06	0.000244	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.04e-06	0.000241	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.68e-06	0.00023	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.61e-06	0.000228	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.53e-06	0.000226	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.22e-06	0.000217	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.21e-06	0.000216	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.11e-06	0.000213	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.9e-06	0.000207	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.88e-06	0.000206	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.87e-06	0.000206	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.81e-06	0.000204	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.73e-06	0.000202	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.66e-06	0.0002	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.57e-06	0.000197	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.53e-06	0.000196	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.51e-06	0.000195	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.48e-06	0.000194	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.26e-06	0.000188	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.16e-06	0.000185	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.07e-06	0.000182	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.97e-06	0.000179	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.87e-06	0.000176	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.83e-06	0.000175	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.7e-06	0.000171	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.6e-06	0.000168	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.54e-06	0.000166	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.53e-06	0.000166	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.38e-06	0.000161	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.28e-06	0.000158	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.27e-06	0.000158	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.08e-06	0.000152	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.06e-06	0.000152	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.98e-06	0.000149	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.81e-06	0.000144	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.73e-06	0.000142	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.67e-06	0.00014	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.6e-06	0.000138	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.58e-06	0.000137	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.43e-06	0.000133	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.34e-06	0.00013	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.29e-06	0.000129	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.26e-06	0.000128	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.18e-06	0.000125	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.11e-06	0.000123	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.07e-06	0.000122	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.06e-06	0.000122	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.83e-06	0.000115	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.77e-06	0.000113	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.7e-06	0.000111	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.58e-06	0.000107	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.27e-06	9.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.11e-06	9.31e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.84e-06	8.52e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-06	8.29e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-06	7.93e-05	CbGpPWpGaD
